 MedIndia | Everolimus in Combination With Exemestane can Improve Disease-free Survival in ... MedIndia Some formulations are approved in the prevention of kidney transplant rejection. In a clinical trial conducted by Novartis, the manufacturer of the drug everolimus under the trade name Afinitor, the use of everolimus was tested in advanced breast ... |
